- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Arteriovenous Graft Thrombosis
Total 5189 results
-
National Cancer Institute (NCI)Genentech, Inc.TerminatedChronic Graft Versus Host DiseaseUnited States
-
Astex Pharmaceuticals, Inc.TerminatedAcute Graft Versus Host DiseaseUnited States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteGateway for Cancer ResearchCompletedGraft vs. Host DiseaseUnited States
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
Ann & Robert H Lurie Children's Hospital of ChicagoDana-Farber Cancer Institute; Fred Hutchinson Cancer Center; University of MinnesotaCompletedGraft vs Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
ActelionTerminatedChronic Graft Versus Host DiseaseUnited States
-
Stanford UniversityCompletedGraft vs Host DiseaseUnited States
-
Karolinska InstitutetKarolinska University HospitalUnknownGraft vs Host DiseaseSweden
-
Guangdong Provincial People's HospitalSun Yat-sen UniversityUnknownGraft Versus Host DiseaseChina
-
Nantes University HospitalCompleted
-
University of RochesterTerminatedChronic Graft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
Rabin Medical CenterUnknownGraft Versus Host DiseaseIsrael
-
University Health Network, TorontoHoffmann-La RocheTerminatedGraft Versus Host DiseaseCanada
-
HenogenWithdrawnAcute Graft Versus Host DiseaseNetherlands
-
University Hospital, AngersUnknownEvaluate the Risks of Using Arteriovenous Fistula as First Choise for Drug AdministrationFrance
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemTerminatedArteriovenous Fistula Complications and FailureUnited States
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; Shenzhen People... and other collaboratorsRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Acute-graft-versus-host DiseaseChina
-
MaaT PharmaRecruitingAcute Graft Versus Host Disease in Intestine | Steroid Refractory GVHDSpain, France, Germany, Austria, Belgium, Italy
-
Seoul National University HospitalRecruitingBrain Neoplasms | Cerebral Aneurysm | Cerebral Arteriovenous Malformation | Navigation, SpatialKorea, Republic of
-
Second Affiliated Hospital, School of Medicine,...RecruitingLocked-In Syndrome;Pulmonary Arteriovenous MalformationChina
-
Beijing Tiantan HospitalUnknownLanguage | AVM - Cerebral Arteriovenous MalformationChina
-
Beijing Tiantan HospitalNot yet recruitingCerebral Arteriovenous MalformationChina
-
Beijing Tiantan HospitalPeking University International HospitalRecruitingArteriovenous Malformation of BrainChina
-
Medical University of ViennaMedical Scientific Fund of the Mayor of ViennaRecruitingCerebral Arteriovenous MalformationAustria
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingCerebral Arteriovenous Malformations | Ruptured or Unruptured Cerebral Arteriovenous MalformationsFrance
-
Peking University People's HospitalRecruitingAcute Graft Versus Host DiseaseChina
-
AHS Cancer Control AlbertaRecruitingRelapse | Graft-versus-host-diseaseCanada
-
Alpine Immune Sciences, Inc.TerminatedGraft Vs Host DiseaseUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedGraft Versus Host DiseaseUnited States
-
Andalusian Initiative for Advanced Therapies -...Andalusian Initiative for Advanced TherapiesCompletedAcute Graft Versus Host DiseaseSpain
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Janssen Pharmaceutical K.K.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedGraft-Versus-Host DiseaseUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedGraft Versus Host DiseaseUnited States
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.CompletedGraft Versus Host DiseaseUnited States
-
David MiklosNovartisCompletedGraft vs Host DiseaseUnited States
-
Medical College of WisconsinTerminatedAcute Graft Versus Host DiseaseUnited States
-
Pharmacyclics LLC.CompletedGraft Versus Host DiseaseUnited States
-
Gilead SciencesTerminatedChronic Graft Versus Host DiseaseSpain, Korea, Republic of, United States, Germany, Canada, France, United Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedGraft Versus Host DiseaseUnited States
-
M.D. Anderson Cancer CenterMallinckrodtCompletedGraft Versus Host DiseaseUnited States
-
University Hospital, CaenUnknownChronic Graft Versus Host DiseaseFrance
-
National Eye Institute (NEI)The Emmes Company, LLCTerminated
-
University of Michigan Rogel Cancer CenterCompletedAcute Graft Versus Host DiseaseUnited States